NCT05346835
68284528MMY4006 EAP: Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-cel) Out-of-Specification (OOS) in Patients With Multiple Myeloma
Associated Conditions
Multiple MyelomaSponsor
Janssen Research & Development, LLC
This study is currently enrolling.